{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:21:35Z","timestamp":1780730495231,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.pt.2026.01.005","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:22:43Z","timestamp":1772428963000},"page":"183-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Breaking the deadlock in antigen discovery for Leishmania vaccines"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9698-7449","authenticated-orcid":false,"given":"Wim","family":"Adriaensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7962-745X","authenticated-orcid":false,"given":"Nicky","family":"de Vrij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3728-6455","authenticated-orcid":false,"given":"Thao-Thy","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8217-2564","authenticated-orcid":false,"given":"Kris","family":"Laukens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5903-633X","authenticated-orcid":false,"given":"Pieter","family":"Meysman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8796-4755","authenticated-orcid":false,"given":"Paul M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2026.01.005_bb0005","first-page":"401","article-title":"Global leishmaniasis surveillance: 2019\u20132020, a baseline for the 2030 roadmap","volume":"35","author":"World Health Organization","year":"2021","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.pt.2026.01.005_bb0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41572-025-00663-w","article-title":"Leishmaniasis","volume":"11","author":"Pareyn","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.pt.2026.01.005_bb0015","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/j.vaccine.2023.01.057","article-title":"Vaccine value profile for leishmaniasis","volume":"41","author":"Kaye","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2026.01.005_bb0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0974-777X.62876","article-title":"Immunological perspectives of leishmaniasis","volume":"2","author":"Nylen","year":"2010","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.pt.2026.01.005_bb0025","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/vaccines7040156","article-title":"Anti-leishmanial vaccines: assumptions, approaches, and annulments","volume":"7","author":"Zutshi","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.pt.2026.01.005_bb0030","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/cid\/ciu102","article-title":"Asymptomatic Leishmania infection: a new challenge for Leishmania control","volume":"58","author":"Singh","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2026.01.005_bb0035","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1080\/14760584.2021.1990043","article-title":"Overcoming roadblocks in the development of vaccines for leishmaniasis","volume":"20","author":"Kaye","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.pt.2026.01.005_bb0040","article-title":"Vaccines for the leishmaniases: proposals for a research agenda","volume":"5","author":"Costa","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2026.01.005_bb0045","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/pathogens13090812","article-title":"Advances in Leishmania vaccines: current development and future prospects","volume":"13","author":"Ayala","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.pt.2026.01.005_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101310","article-title":"A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis","volume":"32","author":"Younis","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.pt.2026.01.005_bb0055","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1038\/s41591-024-03146-9","article-title":"Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis","volume":"30","author":"Parkash","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2026.01.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012707","article-title":"Large-scale randomized double-blind field clinical trial for safety and efficacy assessment of the DNA vaccine Neoleish against canine leishmaniasis","volume":"19","author":"P\u00e1ez","year":"2025","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2026.01.005_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105424","article-title":"Identifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030","volume":"110","author":"Hasso-Agopsowicz","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pt.2026.01.005_bb0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/pathogens11040431","article-title":"The history of live attenuated centrin gene-deleted Leishmania vaccine candidates","volume":"11","author":"Volpedo","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.pt.2026.01.005_bb0075","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4049\/jimmunol.2000517","article-title":"The phosphoenolpyruvate carboxykinase is a key metabolic enzyme and critical virulence factor of Leishmania major","volume":"206","author":"Barazandeh","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.pt.2026.01.005_bb0080","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fimmu.2014.00260","article-title":"Leishmania spp. proteome data sets: a comprehensive resource for vaccine development to target visceral leishmaniasis","volume":"5","author":"Aebischer","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pt.2026.01.005_bb0085","series-title":"ThePrint 20 January, p","author":"Basu","year":"2022"},{"key":"10.1016\/j.pt.2026.01.005_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12699","article-title":"Retracted: evaluating the immunomodulatory responses of Ld ODC-derived MHC Class-II restricted peptides against VL","volume":"42","author":"Pandey","year":"2020","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.pt.2026.01.005_bb0095","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.immuni.2022.07.008","article-title":"Standing on the shoulders of mice","volume":"55","author":"Medetgul-Ernar","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.pt.2026.01.005_bb0100","series-title":"Pathobiology of Parasitic Protozoa: Dynamics and Dimensions","article-title":"An Insight into Immunopathology of Leishmaniasis","author":"Chauhan","year":"2023"},{"key":"10.1016\/j.pt.2026.01.005_bb0105","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jcyt.2023.12.002","article-title":"Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing","volume":"26","author":"Shafer","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.pt.2026.01.005_bb0110","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.4049\/jimmunol.1701764","article-title":"Epitope-binding characteristics for risk versus protective DRB1 alleles for visceral leishmaniasis","volume":"200","author":"Singh","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.pt.2026.01.005_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac5477","article-title":"Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+ T cells","volume":"7","author":"Mou","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pt.2026.01.005_bb0120","article-title":"Immunopeptidomics of cutaneous leishmaniasis patients reveals the natural antigenic landscape","author":"de Vrij","year":"2026","journal-title":"medRxiv"},{"key":"10.1016\/j.pt.2026.01.005_bb0125","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.177.6.3525","article-title":"Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo","volume":"177","author":"Bertholet","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.pt.2026.01.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03537-23","article-title":"Step-by-step: the CD8 T cell journey in leishmaniasis","volume":"16","author":"Fowler","year":"2025","journal-title":"mBio"},{"key":"10.1016\/j.pt.2026.01.005_bb0135","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fimmu.2014.00480","article-title":"Deception and manipulation: the arms of Leishmania, a successful parasite","volume":"5","author":"Cec\u00e3lio","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pt.2026.01.005_bb0140","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.4049\/jimmunol.138.6.1926","article-title":"Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products","volume":"138","author":"Reiner","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.pt.2026.01.005_bb0145","article-title":"Intralysosomal pathogens differentially influence the proteolytic potential of their niche","volume":"e0027025","author":"Bird","year":"2025","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2026.01.005_bb0150","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.pt.2024.07.013","article-title":"The immunomicrotope of Leishmania control and persistence","volume":"40","author":"Bogdan","year":"2024","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2026.01.005_bb0155","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1128\/IAI.72.12.6924-6931.2004","article-title":"The Leishmania major LACK antigen with an immunodominant epitope at amino acids 156 to 173 is not required for early Th2 development in BALB\/c mice","volume":"72","author":"Kelly","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2026.01.005_bb0160","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","article-title":"Immune evasion and provocation by Mycobacterium tuberculosis","volume":"20","author":"Chandra","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.pt.2026.01.005_bb0165","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adw9184","article-title":"Immunopeptidomics can inform the design of mRNA vaccines for the delivery of Mycobacterium tuberculosis MHC class II antigens","volume":"17","author":"Leddy","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pt.2026.01.005_bb0170","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.immuni.2006.09.005","article-title":"Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses","volume":"25","author":"Yewdell","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.pt.2026.01.005_bb0175","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200206","article-title":"Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin","volume":"217","author":"Cassotta","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pt.2026.01.005_bb0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cellimm.2016.07.010","article-title":"Memory T cells in cutaneous leishmaniasis","volume":"309","author":"Glennie","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.pt.2026.01.005_bb0185","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20142101","article-title":"Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection","volume":"212","author":"Glennie","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pt.2026.01.005_bb0190","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41596-019-0133-y","article-title":"Mass spectrometry\u2013based identification of MHC-bound peptides for immunopeptidomics","volume":"14","author":"Purcell","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.pt.2026.01.005_bb0195","first-page":"1","article-title":"Method of the year 2019: single-cell multimodal omics","volume":"17","author":"Editorial","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.pt.2026.01.005_bb0200","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nbt.3662","article-title":"Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes","volume":"34","author":"Bentzen","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pt.2026.01.005_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108613","article-title":"HLAEquity: examining biases in pan-allele peptide-HLA binding predictors","volume":"27","author":"Conev","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.pt.2026.01.005_bb0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41541-019-0148-y","article-title":"Identification of antigens presented by MHC for vaccines against tuberculosis","volume":"5","author":"Bettencourt","year":"2020","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.pt.2026.01.005_bb0215","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84070","article-title":"Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I","volume":"12","author":"Leddy","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.pt.2026.01.005_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012764","article-title":"Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate","volume":"20","author":"Versteeg","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2026.01.005_bb0225","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/nbt.4282","article-title":"High-throughput determination of the antigen specificities of T cell receptors in single cells","volume":"36","author":"Zhang","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pt.2026.01.005_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuno.2022.100009","article-title":"Recent advances in T-cell receptor repertoire analysis: bridging the gap with multimodal single-cell RNA sequencing","volume":"5","author":"Valkiers","year":"2022","journal-title":"ImmunoInformatics"},{"key":"10.1016\/j.pt.2026.01.005_bb0235","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature22976","article-title":"Identifying specificity groups in the T cell receptor repertoire","volume":"547","author":"Glanville","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.pt.2026.01.005_bb0240","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1093\/bioinformatics\/btab446","article-title":"ClusTCR: a python interface for rapid clustering of large sets of CDR3 sequences with unknown antigen specificity","volume":"37","author":"Valkiers","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.pt.2026.01.005_bb0245","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00251-017-1023-5","article-title":"On the feasibility of mining CD8+ T cell receptor patterns underlying immunogenic peptide recognition","volume":"70","author":"De Neuter","year":"2018","journal-title":"Immunogenetics"},{"key":"10.1016\/j.pt.2026.01.005_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/bib\/bbaa318","article-title":"Current challenges for unseen-epitope TCR interaction prediction and a new perspective derived from image classification","volume":"22","author":"Moris","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.pt.2026.01.005_bb0255","article-title":"Generation of a T cell receptor, cytokine and cell repertoire synovial fluid atlas to define commonalities and dissimilarities between arthritic diseases through systems immunology approaches","author":"Ha","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.pt.2026.01.005_bb0260","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41591-022-02110-9","article-title":"T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection","volume":"29","author":"Musvosvi","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2026.01.005_bb0265","doi-asserted-by":"crossref","DOI":"10.1093\/jimmun\/vkaf283.946","article-title":"CD4+ T cell receptor repertoire and antigen-specific T cell responses in people who \u2018resist\u2019 infection of Mycobacterium tuberculosis 3108","volume":"214","author":"Gao","year":"2025","journal-title":"J. Immunol."},{"key":"10.1016\/j.pt.2026.01.005_bb0270","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41590-024-01897-8","article-title":"Specific CD4+ T cell phenotypes associate with bacterial control in people who \u2018resist\u2019 infection with Mycobacterium tuberculosis","volume":"25","author":"Sun","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pt.2026.01.005_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009000","article-title":"A natural polymorphism of Mycobacterium tuberculosis in the esxH gene disrupts immunodomination by the TB10.4-specific CD8 T cell response","volume":"16","author":"Sutiwisesak","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2026.01.005_bb0280","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/22221751.2021.2021808","article-title":"Generation and characterization of genetically and antigenically diverse infectious clones of dengue virus serotypes 1\u20134","volume":"11","author":"Tamura","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.pt.2026.01.005_bb0285","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.immuni.2022.09.002","article-title":"Spatial maps of T cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune response","volume":"55","author":"Liu","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.pt.2026.01.005_bb0290","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1038\/s41467-023-43201-6","article-title":"High-sensitive spatially resolved T cell receptor sequencing with SPTCR-seq","volume":"14","author":"Benotmane","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2026.01.005_bb0295","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/microorganisms8081201","article-title":"Leishmania immunity: advancing immunotherapy and vaccine development","volume":"8","author":"Ikeogu","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.pt.2026.01.005_bb0300","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1473-3099(10)70166-3","article-title":"Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes","volume":"10","author":"Halstead","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2026.01.005_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2024.105353","article-title":"MAPK\/ERK activation in macrophages promotes Leishmania internalization and pathogenesis","volume":"26","author":"Barrie","year":"2024","journal-title":"Microbes Infect."},{"key":"10.1016\/j.pt.2026.01.005_bb0310","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149222600005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149222600005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:34:04Z","timestamp":1773178444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149222600005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S147149222600005X"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2026.01.005","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breaking the deadlock in antigen discovery for Leishmania vaccines","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2026.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}